MIFEPRISTONE AND MISOPROSTOL VERSUS OSMOTIC DILATOR USE PRIOR TO SURGICAL ABORTION AT 15-18 WEEKS: A NONINFERIORITY STUDY

被引：0
|
作者：
Borgatta, L. [1 ]
Sonalkar, S. [1 ]
McClusky, J. [1 ]
Kattan, D. [1 ]
Paris, A. [1 ]
Petricone, R. [1 ]
Finesseth, M. [1 ]
机构：
[1] Boston Univ, Boston, MA 02215 USA
来源：
CONTRACEPTION | 2014年 / 90卷 / 03期
关键词：
D O I：
10.1016/j.contraception.2014.05.052
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P31
引用
收藏
页码：307 / 307
页数：1
相关论文
共 9 条
  • [1] Mifepristone and Misoprostol Compared With Osmotic Dilator Insertion Before Surgical Abortion at 15-18Weeks
    Paris, Amy E.
    Sonalkar, Sarita
    Kattan, David
    McClusky, Jessica
    Vragovic, Olivera
    Borgatta, Lynn
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 5S - 5S
  • [2] Mifepristone and misoprostol compared to osmotic dilators for cervical preparation prior to surgical abortion at 15-18 weeks' gestation: a randomised controlled non-inferiority trial
    Paris, Amy E.
    Vragovic, Olivera
    Sonalkar, Sarita
    Finneseth, Molly
    Borgatta, Lynn
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2020, 46 (01) : 67 - 72
  • [3] MIFEPRISTONE VS. OSMOTIC DILATOR INSERTION FOR CERVICAL PREPARATION PRIOR TO SURGICAL ABORTION AT 14-16 WEEKS
    Borgatta, L.
    Roncari, D.
    Sonalkar, S.
    Mark, A.
    Liford, K.
    Hou, M.
    Finneseth, M.
    CONTRACEPTION, 2011, 84 (03) : 304 - 304
  • [4] Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial
    Creinin, Mitchell D.
    CONTRACEPTION, 2013, 87 (04) : 507 - 508
  • [5] Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial
    Borgatta, Lynn
    Roncari, Danielle
    Sonalkar, Sarita
    Mark, Alice
    Hou, Melody Y.
    Finneseth, Molly
    Vragovic, Olivera
    CONTRACEPTION, 2012, 86 (05) : 567 - 571
  • [6] Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial Response
    Borgatta, Lynn
    Mark, Alice
    CONTRACEPTION, 2013, 87 (04) : 508 - 508
  • [7] Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan
    Platais, Ingrida
    Tsereteli, Tamar
    Grebennikova, Galina
    Lotarevich, Tatyana
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 134 (03) : 268 - 271
  • [8] One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study
    Sium, Abraham Fessehaye
    Teklu, Hana
    Reeves, Matthew
    Tolu, Lemi Belay
    Prager, Sarah
    CONTRACEPTION, 2024, 132
  • [9] Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester surgical abortion (12-16 weeks)
    Nucatola, Deborah
    Roth, Nitzan
    Saulsberry, Vallorie
    Gatter, Mary
    CONTRACEPTION, 2008, 78 (03) : 245 - 248
1